Applications are invited for the Astra Zeneca PhD studentship in Identifying opportunities to overcome the immunosuppressive role of Cancer-Associated Fibroblasts. The post is based primarily in the University of Cambridge Department of Surgery on the Cambridge Biomedical Campus, with some time based at Astra-Zeneca. The proposed start date is October 2024.
Subject: